MLL4/KMT2D mutations increase immune activity and predict therapyefficacy in colorectal cancer
Timothy En Haw Chan, H. T. Marc Timmers
This study shows that KMT2D mutations in colorectal cancer are linked to increased immune activity and better response to immunotherapy and cisplatin.
bioRxiv · Aug 3, 2026 · PreprintCancer Biology